查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1458530

核酸分離與精製市場：全球規模、佔有率、趨勢分析、機會、預測報告，2019-2030

Nucleic Acid Isolation and Purification Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019-2030, Segmented By Product ; By Type ; By Method ; By Application ; By End User ; By Region
出版日期: | 出版商: Blueweave Consulting | 英文 400 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

全球核酸分離精製市場規模將以9.23%的年複合成長率大幅擴張，2030年將達到84.7億美元。

由於RNA療法管道的不斷擴大和基於核酸的診斷的日益普及，全球核酸分離和精製市場正在蓬勃發展。

領先的策略諮詢和市場研究公司BlueWeave Consulting在最近的研究中預計，2023年全球核酸分離精製市場規模為42.2億美元。 BlueWeave預測，2024年至2030年預測期內，全球核酸分離精製市場規模將以9.23%的年複合成長率成長，2030年達到84.7億美元。加強研發力度和增加臨床診斷定序平台的使用是全球核酸分離和精製市場的兩個主要成長要素。基因組研究的增加和新產品的推出預計也將推動市場的發展。

機會：診斷應用的增加

全球核酸分離和精製市場按應用細分為藥物發現/研發、精準醫學、診斷、農業/動物研究等。診斷領域佔全球核酸分離精製市場最大佔有率。根據 ScienceDirect 發表的一項研究，RNA/DNA 基因測試是識別感染疾病和確定一個人對某些疾病（包括 COVID-19）的易感性的最可靠方法。預計藥物發現和開發將在預測期內實現最高成長率。

地緣政治緊張局勢升級對全球核酸分離精製市場的影響

地緣政治緊張局勢的加劇將限制全球核酸分離精製市場的成長。例如，烏克蘭已成為各種疾病（尤其是癌症）臨床研究和臨床實驗的主要目的地。由於存在有組織和數位化的醫療系統，與許多其他西歐國家相比，烏克蘭可以以較低的成本進行醫學研究。然而，俄羅斯對烏克蘭的入侵崩壞了該國的醫學研究生態系統。根據多方通報，烏克蘭擁有大量臨床研究專家以及基礎設施，直接影響核酸分離精製的需求，阻礙全球市場的成長。

全球核酸分離精製市場

按細分市場分類的覆蓋範圍

核酸分離和精製的全球市場 - 按方法分類

全球核酸分離精製市場依方法分為基於試劑的分離精製、基於管柱的分離精製、以微珠為基礎的分離精製等。由於 DNA 和 RNA 分離和精製中檢測性能的提高，以微珠為基礎的分離和精製領域佔據了最高的市場佔有率。此外，與其他方法相比，該方法更快、更容易、更靈活，這使其具有競爭力並受到研究人員和科學家的青睞。

全球核酸分離與精製市場 - 按地區

關於全球核酸分離和精製市場的詳細研究報告涵蓋了五個主要地區的眾多各國市場：北美、歐洲、亞太地區（APAC）、拉丁美洲以及中東和非洲。北美主導全球核酸分離精製市場。市場的推動因素是Thermo Scientific和Bio-Rad Laboratories等主要企業的集中，以及核酸精製系統研發力度和投資的加強。

競爭格局

全球核酸分離和精製市場的主要企業包括安捷倫科技、Bio-Rad Laboratories Inc.、Thermo Fisher Scientific、BioVision Inc.、丹納赫公司、F. Hoffmann-La Roche Ltd.、GE Healthcare、Merck KGaA (Sigma) -Aldrich Corporation)、Promega Corporation、Qiagen NV、Invitek Molecular、Analytik Jena AG、Illumina, Inc. 和Takara Bio Inc.。

為了進一步增加市場佔有率，這些公司正在採取各種策略，例如併購、合作、合資、授權合約和新產品發布。

該報告的詳細分析提供了有關成長潛力、未來趨勢和全球核酸分離與精製市場的資訊。它還涵蓋了推動市場總規模預測的因素。該報告致力於提供全球核酸分離與精製市場的最新技術趨勢以及產業見解，以幫助決策者做出策略決策。此外，我們也分析了市場的成長動力、挑戰和競爭力。

目錄

第1章 研究框架

第 2 章執行摘要

第3章全球核酸分離精製市場洞察

  • 產業價值鏈分析
    • DROC分析
    • 生長促進因子
      • 擴大RNA療法的研發管線
      • 基於核酸的診斷越來越受歡迎
      • 技術進步
      • 擴大研究活動
    • 抑制因素
      • 監管挑戰
      • 成本限制
      • 供應鏈中斷
    • 機會
      • 對先進診斷技術的需求
      • 戰略合作
      • 發展中地區市場拓展
    • 任務
      • 競爭很激烈
      • 技術複雜性
  • 科技進步/最新發展
  • 法律規範
  • 波特五力分析

第4章 全球核酸分離精製市場、價格分析

第5章全球核酸分離精製市場：行銷策略

第6章全球核酸分離精製市場、區域分析

  • 世界市場，區域分析，2023 年
  • 世界市場，吸引力分析，2024-2030

第7章 全球核酸分離精製市場概況

  • 2019-2030年市場最終用戶及預測
    • 按金額
  • 市場佔有率及預測
    • 依產品
      • 套件和試劑
      • 裝置
      • 其他
    • 按類型
      • 質體DNA 的分離與精製
      • 總RNA分離精製
      • 基因組 DNA 分離精製
      • 傳訊RNA分離精製
      • 微型RNA分離精製
      • 循環核酸的分離與精製
      • PCR 純化
      • 其他
    • 依方法
      • 基於試劑的分離與精製
      • 管柱分離精製
      • 使用磁珠分離和精製
      • 其他
    • 按申請
      • 藥物發現與開發
      • 精準醫療
      • 診斷
      • 農業和動物研究
      • 其他
    • 按最終用戶
      • 醫院
      • 診斷中心
      • 學術研究所
      • 合約調查機構
      • 製藥和生物技術公司
      • 其他
    • 按地區
      • 北美洲
      • 歐洲
      • 亞太地區 (APAC)
      • 拉丁美洲 (LATAM)
      • 中東和非洲 (MEA)

第8章 北美核酸分離精製市場

  • 2019-2030年市場最終用戶及預測
    • 按金額
  • 市場佔有率及預測
    • 依產品
    • 按類型
    • 依方法
    • 按申請
    • 按最終用戶
    • 按國家/地區
      • 美國
      • 加拿大

第9章歐洲核酸分離精製市場

  • 2019-2030年市場最終用戶及預測
    • 按金額
  • 市場佔有率及預測
    • 依產品
    • 按類型
    • 依方法
    • 按申請
    • 按最終用戶
    • 按國家/地區
      • 德國
      • 英國
      • 義大利
      • 法國
      • 西班牙
      • 比利時
      • 俄羅斯
      • 荷蘭
      • 其他

第10章亞太地區核酸分離精製市場

  • 2019-2030年市場最終用戶及預測
    • 按金額
  • 市場佔有率及預測
    • 依產品
    • 按類型
    • 依方法
    • 按申請
    • 按最終用戶
    • 按國家/地區
      • 中國
      • 印度
      • 日本
      • 韓國
      • 澳洲和紐西蘭
      • 印尼
      • 馬來西亞
      • 新加坡
      • 越南
      • 其他

第11章 拉丁美洲核酸分離精製市場

  • 2019-2030年市場最終用戶及預測
    • 按金額
  • 市場佔有率及預測
    • 依產品
    • 按類型
    • 依方法
    • 按申請
    • 按最終用戶
    • 按國家/地區
      • 巴西
      • 墨西哥
      • 阿根廷
      • 秘魯
      • 其他

第12章 中東及非洲核酸分離精製市場

  • 2019-2030年市場最終用戶及預測
    • 按金額
  • 市場佔有率及預測
    • 依產品
    • 按類型
    • 依方法
    • 按申請
    • 按最終用戶
    • 按國家/地區
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 卡達
      • 科威特
      • 南非
      • 奈及利亞
      • 阿爾及利亞
      • 其他

第13章競爭格局

  • 主要參與者及其方法列表
  • 2023年全球核酸分離精製企業市場佔有率分析
  • 透過管理參數進行競爭基準化分析
  • 重大策略發展（合併、收購、聯盟等）

第14章地緣政治緊張局勢升級對全球核酸分離精製市場的影響

第15章 公司簡介（公司簡介、財務矩陣、競爭格局、關鍵人員、主要競爭對手、聯絡方式、策略展望、SWOT分析）

  • Agilent Technologies
  • Bio-Rad Laboratories Inc.
  • Thermo Fisher Scientific
  • BioVision Inc.
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd
  • GE Healthcare
  • Merck KGaA（Sigma-Aldrich Corporation）
  • Promega Corporation
  • Qiagen NV
  • Invitek Molecular
  • Analytik Jena AG
  • Illumina, Inc
  • Takara Bio Inc.
  • 其他主要企業

第16章 主要策略建議

第17章調查方法

簡介目錄
Product Code: BWC24238

Global Nucleic Acid Isolation and Purification Market Size Expands at Significant CAGR of 9.23% to Reach USD 8.47 Billion by 2030

Global Nucleic Acid Isolation and Purification Market is flourishing because of the expanding pipeline for RNA therapeutics and growing popularity of nucleic acid-based diagnostics.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated the Global Nucleic Acid Isolation and Purification Market size at USD 4.22 billion in 2023. During the forecast period between 2024 and 2030, BlueWeave expects the Global Nucleic Acid Isolation and Purification Market size to expand at a CAGR of 9.23% reaching a value of USD 8.47 billion by 2030. Growing R&D efforts and an increase in the use of sequencing platforms for clinical diagnostics are two key growth drivers for the Global Nucleic Acid Isolation and Purification Market. The is also expected to be driven by an increase in genomics research as well as new product launches.

Opportunity: Rising application for diagnostics

The Global Nucleic Acid Isolation and Purification Market is segmented into drug discovery & development, precision medicine, diagnostics, agriculture and animal research, and other, based on application. The diagnostics segment holds the largest share in the Global Nucleic Acid Isolation and Purification Market. According to research published on ScienceDirect, RNA/DNA genetic tests are the most reliable for identifying infectious illnesses and determining a person's vulnerability to certain diseases, including COVID-19. Drug discovery and development is anticipated to register the highest growth rate during the forecast period.

Impact of Escalating Geopolitical Tensions on Global Nucleic Acid Isolation and Purification Market

The escalating geopolitical tensions restrict the growth of the Global Nucleic Acid Isolation and Purification Market. For instance, Ukraine has been emerging as the leading destination for clinical research and trials of various diseases, particularly cancer. The presence of an organized and digitized health system makes it cheaper to accommodate medical research in Ukraine compared to many other Western European nations. However, Russia's invasion of Ukraine disrupted the medical research ecosystem in the country. Many reports reveal that Ukraine has a large number of clinical research specialists as well as infrastructure, which directly impacts the demand for nucleic acid isolation and purification, hindering its global market growth.

Global Nucleic Acid Isolation and Purification Market

Segmental Coverage

Global Nucleic Acid Isolation and Purification Market - By Method

Based on method, the Global Nucleic Acid Isolation and Purification Market is segmented into reagent-based isolation & purification, column-based isolation & purification, magnetic bead-based isolation and purification, and others. The magnetic bead-based isolation and purification segment accounts for the highest market share due to improved assay performance in DNA and RNA isolation and purification. Additionally, this method is also faster, easier, and more flexible compared to other methods, which gives it a competitive edge over other methods, and therefore, is preferred by researchers and scientists.

Global Nucleic Acid Isolation and Purification Market - By Region

The in-depth research report on the Global Nucleic Acid Isolation and Purification Market covers a number of country-specific markets across five major regions: North America, Europe, Asia Pacific (APAC), Latin America, the Middle East and Africa. North America dominates the Global Nucleic Acid Isolation and Purification Market. The high concentration of major industry players, such as Thermo Scientific and Bio-Rad Laboratories Inc., and their increasing efforts and investments in the R&D of nucleic acid purification systems are driving the market.

Competitive Landscape

Major players operating in the Global Nucleic Acid Isolation and Purification Market include Agilent Technologies, Bio-Rad Laboratories Inc., Thermo Fisher Scientific, BioVision Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd, GE Healthcare, Merck KGaA (Sigma-Aldrich Corporation), Promega Corporation, Qiagen NV, Invitek Molecular, Analytik Jena AG, Illumina, Inc., and Takara Bio Inc.

To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and the Global Nucleic Acid Isolation and Purification Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in the Global Nucleic Acid Isolation and Purification Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

Table of Contents

1. Research Framework

  • 1.1. Research Objective
  • 1.2. Product Overview
  • 1.3. Market Segmentation

2. Executive Summary

3. Global Nucleic Acid Isolation and Purification Market Insights

  • 3.1. Industry Value Chain Analysis
    • 3.1.1. DROC Analysis
    • 3.1.2. Growth Drivers
      • 3.1.2.1. Expanding Pipeline for RNA Therapeutics
      • 3.1.2.2. Growing Popularity of Nucleic Acid-based Diagnostics
      • 3.1.2.3. Technological Advancements
      • 3.1.2.4. Increasing Research Activities
    • 3.1.3. Restraints
      • 3.1.3.1. Regulatory Challenges
      • 3.1.3.2. Cost Constraints
      • 3.1.3.3. Supply Chain Disruptions
    • 3.1.4. Opportunities
      • 3.1.4.1. Advanced Diagnostic Techniques Demand
      • 3.1.4.2. Strategic Collaborations
      • 3.1.4.3. Market Expansion in Developing Regions
    • 3.1.5. Challenges
      • 3.1.5.1. High Competition
      • 3.1.5.2. Technological Complexity
  • 3.2. Technological Advancements/Recent Developments
  • 3.3. Regulatory Framework
  • 3.4. Porter's Five Forces Analysis
    • 3.4.1. Bargaining Power of Suppliers
    • 3.4.2. Bargaining Power of Buyers
    • 3.4.3. Threat of New Entrants
    • 3.4.4. Threat of Substitutes
    • 3.4.5. Intensity of Rivalry

4. Global Nucleic Acid Isolation and Purification Market, Pricing Analysis

5. Global Nucleic Acid Isolation and Purification Market: Marketing Strategies

6. Global Nucleic Acid Isolation and Purification Market, Geographical Analysis

  • 6.1. Global Nucleic Acid Isolation and Purification Market, Geographical Analysis, 2023
  • 6.2. Global Lateral Flow Assays, Market Attractiveness Analysis, 2024-2030

7. Global Nucleic Acid Isolation and Purification Market Overview

  • 7.1. Market End User & Forecast, 2019-2030
    • 7.1.1. By Value (USD Billion)
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
      • 7.2.1.1. Kits & Reagents
      • 7.2.1.2. Instruments
      • 7.2.1.3. Others
    • 7.2.2. By Type
      • 7.2.2.1. Plasmid DNA Isolation & Purification
      • 7.2.2.2. Total RNA Isolation & Purification
      • 7.2.2.3. Genomic DNA Isolation & Purification
      • 7.2.2.4. Messenger RNA Isolation & Purification
      • 7.2.2.5. Micro RNA Isolation & Purification
      • 7.2.2.6. Circulating Nucleic Acid Isolation & Purification
      • 7.2.2.7. PCR Cleanup
      • 7.2.2.8. Others
    • 7.2.3. By Method
      • 7.2.3.1. Reagent-based Isolation & Purification
      • 7.2.3.2. Column-based Isolation & Purification
      • 7.2.3.3. Magnetic Bead-based Isolation & Purification
      • 7.2.3.4. Others
    • 7.2.4. By Application
      • 7.2.4.1. Drug Discovery & Development
      • 7.2.4.2. Precision Medicine
      • 7.2.4.3. Diagnostics
      • 7.2.4.4. Agriculture & Animal Research
      • 7.2.4.5. Others
    • 7.2.5. By End User
      • 7.2.5.1. Hospitals
      • 7.2.5.2. Diagnostic Centers
      • 7.2.5.3. Academic & Research Institutes
      • 7.2.5.4. Contract Research Organizations
      • 7.2.5.5. Pharmaceutical & Biotechnology Companies
      • 7.2.5.6. Others
    • 7.2.6. By Region
      • 7.2.6.1. North America
      • 7.2.6.2. Europe
      • 7.2.6.3. Asia Pacific (APAC)
      • 7.2.6.4. Latin America (LATAM)
      • 7.2.6.5. Middle East and Africa (MEA)

8. North America Nucleic Acid Isolation and Purification Market

  • 8.1. Market End User & Forecast, 2019-2030
    • 8.1.1. By Value (USD Billion)
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Type
    • 8.2.3. By Method
    • 8.2.4. By Application
    • 8.2.5. By End User
    • 8.2.6. By Country
      • 8.2.6.1. United States
      • 8.2.6.1.1. By Product
      • 8.2.6.1.2. By Type
      • 8.2.6.1.3. By Method
      • 8.2.6.1.4. By Application
      • 8.2.6.1.5. By End User
      • 8.2.6.2. Canada
      • 8.2.6.2.1. By Product
      • 8.2.6.2.2. By Type
      • 8.2.6.2.3. By Method
      • 8.2.6.2.4. By Application
      • 8.2.6.2.5. By End User

9. Europe Nucleic Acid Isolation and Purification Market

  • 9.1. Market End User & Forecast, 2019-2030
    • 9.1.1. By Value (USD Billion)
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Type
    • 9.2.3. By Method
    • 9.2.4. By Application
    • 9.2.5. By End User
    • 9.2.6. By Country
      • 9.2.6.1. Germany
      • 9.2.6.1.1. By Product
      • 9.2.6.1.2. By Type
      • 9.2.6.1.3. By Method
      • 9.2.6.1.4. By Application
      • 9.2.6.1.5. By End User
      • 9.2.6.2. United Kingdom
      • 9.2.6.2.1. By Product
      • 9.2.6.2.2. By Type
      • 9.2.6.2.3. By Method
      • 9.2.6.2.4. By Application
      • 9.2.6.2.5. By End User
      • 9.2.6.3. Italy
      • 9.2.6.3.1. By Product
      • 9.2.6.3.2. By Type
      • 9.2.6.3.3. By Method
      • 9.2.6.3.4. By Application
      • 9.2.6.3.5. By End User
      • 9.2.6.4. France
      • 9.2.6.4.1. By Product
      • 9.2.6.4.2. By Type
      • 9.2.6.4.3. By Method
      • 9.2.6.4.4. By Application
      • 9.2.6.4.5. By End User
      • 9.2.6.5. Spain
      • 9.2.6.5.1. By Product
      • 9.2.6.5.2. By Type
      • 9.2.6.5.3. By Method
      • 9.2.6.5.4. By Application
      • 9.2.6.5.5. By End User
      • 9.2.6.6. Belgium
      • 9.2.6.6.1. By Product
      • 9.2.6.6.2. By Type
      • 9.2.6.6.3. By Method
      • 9.2.6.6.4. By Application
      • 9.2.6.6.5. By End User
      • 9.2.6.7. Russia
      • 9.2.6.7.1. By Product
      • 9.2.6.7.2. By Type
      • 9.2.6.7.3. By Method
      • 9.2.6.7.4. By Application
      • 9.2.6.7.5. By End User
      • 9.2.6.8. The Netherlands
      • 9.2.6.8.1. By Product
      • 9.2.6.8.2. By Type
      • 9.2.6.8.3. By Method
      • 9.2.6.8.4. By Application
      • 9.2.6.8.5. By End User
      • 9.2.6.9. Rest of Europe
      • 9.2.6.9.1. By Product
      • 9.2.6.9.2. By Type
      • 9.2.6.9.3. By Method
      • 9.2.6.9.4. By Application
      • 9.2.6.9.5. By End User

10. Asia Pacific Nucleic Acid Isolation and Purification Market

  • 10.1. Market End User & Forecast, 2019-2030
    • 10.1.1. By Value (USD Billion)
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Type
    • 10.2.3. By Method
    • 10.2.4. By Application
    • 10.2.5. By End User
    • 10.2.6. By Country
      • 10.2.6.1. China
      • 10.2.6.1.1. By Product
      • 10.2.6.1.2. By Type
      • 10.2.6.1.3. By Method
      • 10.2.6.1.4. By Application
      • 10.2.6.1.5. By End User
      • 10.2.6.2. India
      • 10.2.6.2.1. By Product
      • 10.2.6.2.2. By Type
      • 10.2.6.2.3. By Method
      • 10.2.6.2.4. By Application
      • 10.2.6.2.5. By End User
      • 10.2.6.3. Japan
      • 10.2.6.3.1. By Product
      • 10.2.6.3.2. By Type
      • 10.2.6.3.3. By Method
      • 10.2.6.3.4. By Application
      • 10.2.6.3.5. By End User
      • 10.2.6.4. South Korea
      • 10.2.6.4.1. By Product
      • 10.2.6.4.2. By Type
      • 10.2.6.4.3. By Method
      • 10.2.6.4.4. By Application
      • 10.2.6.4.5. By End User
      • 10.2.6.5. Australia & New Zealand
      • 10.2.6.5.1. By Product
      • 10.2.6.5.2. By Type
      • 10.2.6.5.3. By Method
      • 10.2.6.5.4. By Application
      • 10.2.6.5.5. By End User
      • 10.2.6.6. Indonesia
      • 10.2.6.6.1. By Product
      • 10.2.6.6.2. By Type
      • 10.2.6.6.3. By Method
      • 10.2.6.6.4. By Application
      • 10.2.6.6.5. By End User
      • 10.2.6.7. Malaysia
      • 10.2.6.7.1. By Product
      • 10.2.6.7.2. By Type
      • 10.2.6.7.3. By Method
      • 10.2.6.7.4. By Application
      • 10.2.6.7.5. By End User
      • 10.2.6.8. Singapore
      • 10.2.6.8.1. By Product
      • 10.2.6.8.2. By Type
      • 10.2.6.8.3. By Method
      • 10.2.6.8.4. By Application
      • 10.2.6.8.5. By End User
      • 10.2.6.9. Vietnam
      • 10.2.6.9.1. By Product
      • 10.2.6.9.2. By Type
      • 10.2.6.9.3. By Method
      • 10.2.6.9.4. By Application
      • 10.2.6.9.5. By End User
      • 10.2.6.10. Rest of APAC
      • 10.2.6.10.1. By Product
      • 10.2.6.10.2. By Type
      • 10.2.6.10.3. By Method
      • 10.2.6.10.4. By Application
      • 10.2.6.10.5. By End User

11. Latin America Nucleic Acid Isolation and Purification Market

  • 11.1. Market End User & Forecast, 2019-2030
    • 11.1.1. By Value (USD Billion)
  • 11.2. Market Share & Forecast
    • 11.2.1. By Product
    • 11.2.2. By Type
    • 11.2.3. By Method
    • 11.2.4. By Application
    • 11.2.5. By End User
    • 11.2.6. By Country
      • 11.2.6.1. Brazil
      • 11.2.6.1.1. By Product
      • 11.2.6.1.2. By Type
      • 11.2.6.1.3. By Method
      • 11.2.6.1.4. By Application
      • 11.2.6.1.5. By End User
      • 11.2.6.2. Mexico
      • 11.2.6.2.1. By Product
      • 11.2.6.2.2. By Type
      • 11.2.6.2.3. By Method
      • 11.2.6.2.4. By Application
      • 11.2.6.2.5. By End User
      • 11.2.6.3. Argentina
      • 11.2.6.3.1. By Product
      • 11.2.6.3.2. By Type
      • 11.2.6.3.3. By Method
      • 11.2.6.3.4. By Application
      • 11.2.6.3.5. By End User
      • 11.2.6.4. Peru
      • 11.2.6.4.1. By Product
      • 11.2.6.4.2. By Type
      • 11.2.6.4.3. By Method
      • 11.2.6.4.4. By Application
      • 11.2.6.4.5. By End User
      • 11.2.6.5. Rest of LATAM
      • 11.2.6.5.1. By Product
      • 11.2.6.5.2. By Type
      • 11.2.6.5.3. By Method
      • 11.2.6.5.4. By Application
      • 11.2.6.5.5. By End User

12. Middle East and Africa Nucleic Acid Isolation and Purification Market

  • 12.1. Market End User & Forecast, 2019-2030
    • 12.1.1. By Value (USD Billion)
  • 12.2. Market Share & Forecast
    • 12.2.1. By Product
    • 12.2.2. By Type
    • 12.2.3. By Method
    • 12.2.4. By Application
    • 12.2.5. By End User
    • 12.2.6. By Country
      • 12.2.6.1. Saudi Arabia
      • 12.2.6.1.1. By Product
      • 12.2.6.1.2. By Type
      • 12.2.6.1.3. By Method
      • 12.2.6.1.4. By Application
      • 12.2.6.1.5. By End User
      • 12.2.6.2. UAE
      • 12.2.6.2.1. By Product
      • 12.2.6.2.2. By Type
      • 12.2.6.2.3. By Method
      • 12.2.6.2.4. By Application
      • 12.2.6.2.5. By End User
      • 12.2.6.3. Qatar
      • 12.2.6.3.1. By Product
      • 12.2.6.3.2. By Type
      • 12.2.6.3.3. By Method
      • 12.2.6.3.4. By Application
      • 12.2.6.3.5. By End User
      • 12.2.6.4. Kuwait
      • 12.2.6.4.1. By Product
      • 12.2.6.4.2. By Type
      • 12.2.6.4.3. By Method
      • 12.2.6.4.4. By Application
      • 12.2.6.4.5. By End User
      • 12.2.6.5. South Africa
      • 12.2.6.5.1. By Product
      • 12.2.6.5.2. By Type
      • 12.2.6.5.3. By Method
      • 12.2.6.5.4. By Application
      • 12.2.6.5.5. By End User
      • 12.2.6.6. Nigeria
      • 12.2.6.6.1. By Product
      • 12.2.6.6.2. By Type
      • 12.2.6.6.3. By Method
      • 12.2.6.6.4. By Application
      • 12.2.6.6.5. By End User
      • 12.2.6.7. Algeria
      • 12.2.6.7.1. By Product
      • 12.2.6.7.2. By Type
      • 12.2.6.7.3. By Method
      • 12.2.6.7.4. By Application
      • 12.2.6.7.5. By End User
      • 12.2.6.8. Rest of MEA
      • 12.2.6.8.1. By Product
      • 12.2.6.8.2. By Type
      • 12.2.6.8.3. By Method
      • 12.2.6.8.4. By Application
      • 12.2.6.8.5. By End User

13. Competitive Landscape

  • 13.1. List of Key Players and Their Methods
  • 13.2. Global Nucleic Acid Isolation and Purification Company Market Share Analysis, 2023
  • 13.3. Competitive Benchmarking, By Operating Parameters
  • 13.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)

14. Impact of Escalating Geopolitical Tensions on Global Nucleic Acid Isolation and Purification Market

15. Company Profiles (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, and SWOT Analysis)

  • 15.1. Agilent Technologies
  • 15.2. Bio-Rad Laboratories Inc.
  • 15.3. Thermo Fisher Scientific
  • 15.4. BioVision Inc.
  • 15.5. Danaher Corporation
  • 15.6. F. Hoffmann-La Roche Ltd
  • 15.7. GE Healthcare
  • 15.8. Merck KGaA (Sigma-Aldrich Corporation)
  • 15.9. Promega Corporation
  • 15.10. Qiagen NV
  • 15.11. Invitek Molecular
  • 15.12. Analytik Jena AG
  • 15.13. Illumina, Inc
  • 15.14. Takara Bio Inc.
  • 15.15. Other Prominent Players

16. Key Strategic Recommendations

17. Research Methodology

  • 17.1. Qualitative Research
    • 17.1.1. Primary & Secondary Research
  • 17.2. Quantitative Research
  • 17.3. Market Breakdown & Data Triangulation
    • 17.3.1. Secondary Research
    • 17.3.2. Primary Research
  • 17.4. Breakdown of Primary Research Respondents, By Region
  • 17.5. Assumptions & Limitations